Cleared Traditional

CMV IGM ANTIBODY TEST (INDIRECT ENZYME TEST)

K893466 · Immuno Concepts, Inc. · Microbiology
Jul 1989
Decision
72d
Days
Class 2
Risk

About This 510(k) Submission

K893466 is an FDA 510(k) clearance for the CMV IGM ANTIBODY TEST (INDIRECT ENZYME TEST), a Antibody Igm,if, Cytomegalovirus Virus (Class II — Special Controls, product code LKQ), submitted by Immuno Concepts, Inc. (Sacramento, US). The FDA issued a Cleared decision on July 14, 1989, 72 days after receiving the submission on May 3, 1989. This device falls under the Microbiology review panel. Regulated under 21 CFR 866.3175.

Submission Details

510(k) Number K893466 FDA.gov
FDA Decision Cleared SESE
Date Received May 03, 1989
Decision Date July 14, 1989
Days to Decision 72 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary —

Device Classification

Product Code LKQ — Antibody Igm,if, Cytomegalovirus Virus
Device Class Class II — Special Controls
CFR Regulation 21 CFR 866.3175

Similar Devices — LKQ Antibody Igm,if, Cytomegalovirus Virus

All 17
IMMULITE 2000 CMV IGM, IMMULITE CMV IGM CONTROLS, AND IMMULITE 200 CMV IGM ADJUSTOR MODEL L2KCM2, L2KCM6, LCMC1, LCMC2,
K100433 · Siemens Healthcare Diagnostics · May 2010
ACCURUN 146 CMV IGM POSITIVE CONTROL
K972884 · Boston Biomedica, Inc. · Aug 1997
VIDAS CMV IGM ASSAY
K933549 · Biomerieux Vitek, Inc. · Aug 1994
BARTELS CYTOMEGALOVIRUS IGM EIA
K922580 · Baxter Diagnostics, Inc. · Apr 1993
ELISA CMV IGM
K914789 · Sclavo, Inc. · Mar 1992
OPUS(R) ANTI CMV-M
K913080 · Pb Diagnostics, Inc. · Oct 1991